Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

When you buy through our links, we may earn a commission. Learn more› By Kathryn Rath and Nena Farrell We’ve added radios from Hearth & Hand, C.Crane, and Sangean to What to look forward to ...

Appear, the Oslo-based live production technology company, is heading to the 2025 NAB Show with a focus on its just-released VX Media Gateway. The product enables broadcasters to optimize their ...

We may not all find the same things funny but all cultures in the world laugh. Why do we love dogs? Dogs evolved from wolves but why did they choose us humans to be their best friends? 10 Places ...

The Nova Scotia-headquartered manufacturer of AM and FM radio broadcast transmitters is heading to the 2025 NAB Show with two new features for its VX Fm transmitter series. For Nautel ...

Live ball-by-ball commentary of Lucknow Super Giants v Punjab Kings in the IPL. Mumbai Indians v Kolkata Knight Riders Live ball-by-ball commentary of Mumbai Indians v Kolkata Knight Riders in the ...